arrow
Back
P

Peter A. Fasching

Friedrich-Alexander University Erlangen-Nuremberg and University Hospital Erlangen

121H-index
2.1KPaper Count
7.9WCitation Count
Published Papers 485
Publication Date
Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial
err2026-07-13
err0
PREAI
errNicholas C Turner; Erica L Mayer; Yeon Hee Park; Wolfgang Janni; Cynthia Ma; Massimo Cristofanilli; Giampaolo Bianchini; Kevin Kalinsky; Hiroji Iwata; Stephen Chia; Adam M Brufsky; Peter A Fasching; Zbigniew Nowecki; Javier Pascual; Nuri Karadurmus; Einav Gal-Yam; Wei-Pang Chung; Seock-Ah Im; Alberto Zambelli; Florence Dalenc
errShare
errSave
Prenatal Alcohol Exposure Predicts Academic Outcomes from Childhood to Adolescence: A Prospective Longitudinal Study Based on Meconium Ethyl Glucuronide
err2026-05-07
err0
errOAAI
errStefan Mestermann; Maike Broich; Peter A. Fasching; Matthias W. Beckmann; Oliver Kratz; Jonas Hemetsberger; Maximilian Bailer; Bernd Lenz; Johannes Kornhuber; Anna Eichler; the IMAC-Mind-Consortium
errShare
errSave
Chemotherapy-Induced Nausea and Vomiting in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy With Fluorouracil, Epirubicin, Cyclophosphamide Followed by Docetaxel Versus an Anthracycline-Free Regimen With Docetaxel, Cyclophosphamide—Results From a Randomized Clinical Trial
err2026-04-29
err0
errOAAI
errManuel Hörner; Henning Schäffler; Lothar Häberle; Chloë Goossens; Kerstin Pfister; Elena Leinert; Kristina Veselinovic; Sara Y. Brucker; Uwe Köhler; Georg Heinrich; Andreas Schneeweiss; Matthias W. Beckmann; Peter A. Fasching; Wolfgang Janni; Brigitte Rack; Sabine Heublein; Philipp Ziegler
errShare
errSave
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma
err2026-04-01
err0
errOAAI
errTibor A. Zwimpfer; Sian Fereday; Ahwan Pandey; Dinuka Ariyaratne; Madawa W. Jayawardana; Laura Twomey; Céline M. Laumont; Catherine J. Kennedy; Adelyn Bolithon; Nicola S. Meagher; Katy Milne; Phineas Hamilton; Jennifer Alsop; Antonis C. Antoniou; George Au-Yeung; Matthias W. Beckmann; Amy Berrington de Gonzalez; Christiani Bisinotto; Freya Blome; Clara Bodelon; Jessica Boros; Alison H. Brand; Michael E. Carney; Alicia Cazorla-Jiménez; Derek S. Chiu; Elizabeth L. Christie; Anita Chudecka-Głaz; Penny Coulson; Kara L. Cushing-Haugen; Cezary Cybulski; Kathleen M. Darcy; Cath David; Trent Davidson; Arif B. Ekici; Esther Elishaev; Julius Emons; Tobias Engler; Rhonda Farrell; Anna Fischer; Montserrat García-Closas; Aleksandra Gentry-Maharaj; Prafull Ghatage; Rosalind Glasspool; Philipp Harter; Andreas D. Hartkopf; Arndt Hartmann; Sebastian Heikaus; Brenda Y. Hernandez; Anusha Hettiaratchi; Sabine Heublein; David G. Huntsman; Mercedes Jimenez-Linan; Michael E. Jones; Eunyoung Kang; Ewa Kaznowska; Tomasz Kluz; Felix K. F. Kommoss; Gottfried Konecny; Roy F. P. M. Kruitwagen; Jessica Kwon; Diether Lambrechts; Cheng-Han Lee; Jenny Lester; Samuel C. Y. Leung; Yee Leung; Anna Linder; Jolanta Lissowska; Liselore Loverix; Jan Lubiński; Constantina Mateoiu; Iain A. McNeish; Malak Moubarak; Gregg S. Nelson; Nikilyn Nevins; Alexander B. Olawaiye; Siel Olbrecht; Sandra Orsulic; Ana Osorio; Carmel M. Quinn; Ganendra Raj Mohan; Isabelle Ray-Coquard; Cristina Rodríguez-Antona; Patricia Roxburgh; Matthias Ruebner; Stuart G. Salfinger; Spinder Samra; Minouk J. Schoemaker; Hans-Peter Sinn; Gabe S. Sonke; Linda Steele; Colin J. R. Stewart; Aline Talhouk; Adeline Tan; Christopher M. Tarney; Sarah E. Taylor; Koen K. Van de Vijver; Maaike A. van der Aa; Toon Van Gorp; Els Van Nieuwenhuysen; Lilian Van-Wagensveld; Andrea E. Wahner-Hendrickson; Christina Walter; Chen Wang; Julia Welz; Nicolas Wentzensen; Lynne R. Wilkens; Stacey J. Winham; Boris Winterhoff; Michael S. Anglesio; Andrew Berchuck; Francisco J. Candido dos Reis; Paul A. Cohen; Thomas P. Conrads; Philip Crowe; Jennifer A. Doherty; Peter A. Fasching; Renée T. Fortner; María J. García; Simon A. Gayther; Marc T. Goodman; Jacek Gronwald; Holly R. Harris; Florian Heitz; Hugo M. Horlings; Beth Y. Karlan; Linda E. Kelemen; G. Larry Maxwell; Usha Menon; Francesmary Modugno; Susan L. Neuhausen; Joellen M. Schildkraut; Annette Staebler; Karin Sundfeldt; Anthony J. Swerdlow; Ignace Vergote; Anna H. Wu; James D. Brenton; Paul D. P. Pharoah; Celeste Leigh Pearce; Malcolm C. Pike; Ellen L. Goode; Susan J. Ramus; Martin Köbel; Brad H. Nelson; Anna DeFazio; Michael L. Friedlander; David D. L. Bowtell; Dale W. Garsed
errShare
errSave
Using smart devices for prenatal care: Assessing the willingness among women with pregnancy-related anxiety
err2026-01-27
err0
errOAAI
errStefanie Altmannshofer; Filip Weidenthaler; Adriana Titzmann; Constanza A Pontones; Nina Danzberger; Katharina M Jaeger; Michael Nissen; Heike Leutheuser; Bjoern M Eskofier; Peter A Fasching; Matthias W Beckmann; Hanna Huebner
errShare
errSave
Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX)
err2025-11-27
err0
errOAAI
errT. Link; M. Reinisch; M. Just; M. Untch; N. Filmann; O. Stötzer; C. Denkert; V. Bjelic-Radisic; P. Wimberger; M. Thill; K. Rhiem; J. Huober; C. Solbach; C. Hanusch; K. Engels; P.A. Fasching; A. Schneeweiss; V. Nekljudova; J. Holtschmidt; J.-U. Blohmer
errShare
errSave
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials
err2025-11-24
err0
PREAI
errFabio Conforti; Johannes Holtschmidt; Valentina Nekljudova; Isabella Sala; Eleonora Pagan; Christine Solbach; Michael Untch; Carsten Denkert; Vincenzo Bagnardi; Laura Pala; Peter A Fasching; Andreas Schneeweiss; Hans-Joachim Lück; Giuseppe Viale; Tommaso De Pas; Marion van Mackelenbergh; Jens Huober; Volkmar Müller; Theresa Link; Thomas Karn
errShare
errSave
Evaluating the potential of ChatGPT for patient identification in clinical breast cancer trials
err2025-11-20
err0
errOAAI
errAnnika Krückel; Peter A Fasching; Oliver Schleicher; Julia Gocke; Lena Brückner; Katharina Seitz; Lothar Häberle; Felix Heindl; Carolin C Hack; Matthias W Beckmann; Julius Emons
errShare
errSave
Study Protocol of SURVIVE HERoes (NCT06643585): Trastuzumab Deruxtecan for molecular relapse in HER2+/ Low early breast cancer with ctDNA positivity after primary therapy
err2025-11-19
err0
PREAI
errPfister, Kerstin; Friedl, Thomas W. P.; Hartkopf, Andreas; Mergel, Franziska; Huesmann, Sophia; Mehmeti, Forca; Schaffler, Henning; Fink, Angelina; Braun, Tatjana; Heublein, Sabine; Wiesmuller, Lisa; Pantel, Klaus; Rack, Brigitte; Fasching, Peter A.; Janni, Wolfgang
errShare
errSave
Cross-sectional study on user requirements for developing a digital patient navigator app
err2025-10-28
err0
errOAAI
errKatharina Seitz; Manuela Langbein; Chloë Goossens; Stefanie Altmannshofer; Peter A. Fasching; Carolin C. Hack; Felix Heindl; Matthias W. Beckmann; Julius Emons; Hanna Huebner
errShare
errSave
Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival☆
err2025-10-17
err0
errOAAI
errJ. Crown; D. Stroyakovskii; D.A. Yardley; C.-S. Huang; P.A. Fasching; A. Bardia; S. Chia; S.-A. Im; M. Martin; B. Xu; C.H. Barrios; M. Untch; R. Moroose; S.A. Hurvitz; G.N. Hortobagyi; D.J. Slamon; F. Visco; G. Spera; J.P. Zarate; D. Halligan; Z. Li; S. Loi
errShare
errSave
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025
err2025-09-17
err0
PREAI
errToralf Reimer; Thorsten Kuehn; Volkmar Mueller; Nina Ditsch; Tanja Fehm; Ute-Susann Albert; Rupert Bartsch; Ingo Bauerfeind; Vesna Bjelic-Radisic; Jens-Uwe Blohmer; Wilfried Budach; Peter Dall; Eva Maria Fallenberg; Peter A. Fasching; Michael Friedrich; Bernd Gerber; Oleg Gluz; Nadia Harbeck; Andreas Hartkopf; Joerg Heil; Juliane Hoerner-Rieber; Jens Huober; Wolfgang Janni; Hans-Heinrich Kreipe; David Krug; Sherko Kuemmel; Sibylle Loibl; Diana Lueftner; Michael Patrick Lux; Nicolai Maass; Christoph Mundhenke; Tjoung-Won Park-Simon; Mattea Reinisch; Kerstin Rhiem; Achim Rody; Marcus Schmidt; Andreas Schneeweiss; Florian Schuetz; Hans-Peter Sinn; Christine Solbach; Erich-Franz Solomayer; Elmar Stickeler; Christoph Thomssen; Michael Untch; Marion van Mackelenbergh; Isabell Witzel; Achim Woeckel; Rachel Wuerstlein; Maggie Banys-Paluchowski; Marc Thill
errShare
errSave
Analyzing and adapting diffusion segmentation behavior for medical images
err2025-08-27
err0
errOAAI
errMathias Öttl; Siyuan Mei; Frauke Wilm; Jingna Qiu; Jana Steenpass; Matthias Rübner; Arndt Hartmann; Hanna Hübner; Peter Fasching; Andreas Maier; Ramona Erber; Katharina Breininger
errShare
errSave
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer
err2025-08-05
err0
errOAAI
errLaura L. Michel; Philipp Ziegler; Philipp Kreis; Andreas D. Hartkopf; Markus Wallwiener; Lothar Häberle; Nelson John; Hans-Christian Kolberg; Peyman Hadji; Hans Tesch; Johannes Ettl; Diana Lüftner; Volkmar Müller; Erik Belleville; Pauline Wimberger; Hans-Martin Enzinger; Hanna Huebner; Sabrina Uhrig; Carolin C. Hack; Petra Krabisch; Peter A. Fasching; Rachel Wuerstlein; Michael Untch; Nina Ditsch; Alexander Hein; Wolfgang Janni; Florin-Andrei Taran; Michael P. Lux; Diethelm Wallwiener; Sara Y. Brucker; Tanja N. Fehm; Andreas Schneeweiss; Chloë Goossens; Tobias Engler
errShare
errSave
Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk
errBREAST
IF7.9
err2025-06-01
err0
errOAAI
errMueller, Volkmar; Hoerner, Manuel; Thill, Marc; Banys-Paluchowski, Maggie; Schmatloch, Sabine; Fasching, Peter A.; Harbeck, Nadia; Langanke, Dagmar; Uhrig, Sabrina; Haeberle, Lothar; Fischer, Dorothea; Hein, Alexander; Fehm, Tanja N.; Goossens, Chloe; Terhaag, Juergen; Heilenkoetter, Uwe; Dall, Peter; Rudlowski, Christian; Wuerstlein, Rachel; Aydogdu, Mustafa; Keyver-Paik, Mignon-Denise; Hammerle, Carolin; Deuerling, Natalija; Stickeler, Elmar; Aktas, Bahriye; Belleville, Erik; Thoma, Martin; Ditsch, Nina; Baila, Yasmin; Roos, Christian; Mann, Christian; Juliano, Caterina; Brucker, Sara Y.; Schneeweiss, Andreas; Hartkopf, Andreas D.
errShare
errSave
Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study
err2025-06-01
err0
PREAI
errT. Decker; C. Brucker; A. Engel; P.A. Fasching; T. Göhler; C. Jackisch; J. Janssen; A. Köhler; K. Lüdtke-Heckenkamp; D. Lüftner; F. Marmé; M. van Mackelenbergh; B. Rautenberg; M. Schmidt; R. Weide; P. Wimberger; E. Kisseleff; C. Pfister; C. Roos; N. Wilhelm; A. Wöckel
errShare
errSave
Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2-early breast cancer
errBREAST
IF7.9
err2025-06-01
err0
errOAAI
errO'Shaughnessy, Joyce; Tolaney, Sara M.; Yardley, Denise A.; Hart, Lowell; Razavi, Pedram; Fasching, Peter A.; Janni, Wolfgang; Schwartzberg, Lee; Kim, Julia; Akdere, Murat; McDermott, Courtney; Khakwani, Aamir; Pathak, Purnima; Graff, Stephanie L.
errShare
errSave
Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantification
err2025-05-14
err0
errOAAI
errGalas, Kristin; Gleitsmann, Moritz; Rey, Julia; Solbach, Christine; Witzel, Isabell; Karn, Thomas; Schmatloch, Sabine; Schem, Christian; Schneeweis, Andreas; Sinn, Bruno; Fehm, Tanja; Denkert, Carsten; Fasching, Peter; Litmeyer, Anne-Sophie; Marme, Frederik; Jank, Paul; Mueller, Volkmar; Seiler, Sabine; Stickeler, Elmar; Ortmann, Olaf; van Mackelenbergh, Marion; Nekljudova, Valentina; Holtschmidt, Johannes; Loibl, Sibylle
errShare
errSave
Improving quality of care for cancer patients through oncological second opinions in a Comprehensive Cancer Center: adherence to second-opinion therapy recommendations
err2025-04-02
err0
errOAAI
errSchulmeyer, Carla; Fasching, Peter A.; Beckmann, Matthias W.; Haeberle, Lothar; Golcher, Henriette; Goebell, Peter J.; Poeschke, Patrik; Emons, Julius
errShare
errSave
Characteristics and prognosis of patients with primary metastatic disease vs. recurrent HER2-negative, hormone receptor-positive advanced breast cancer
errBREAST
IF7.9
err2025-04-01
err0
errOAAI
errWalter, Christina B.; Hartkopf, Andreas D.; Hein, Alexander; Fasching, Peter A.; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Haberle, Lothar; Ettl, Johannes; Luftner, Diana; Wallwiener, Markus; Muller, Volkmar; Beckmann, Matthias W.; Michel, Laura L.; Belleville, Erik; Huebner, Hanna; Uhrig, Sabrina; Goossens, Chloe; Wimberger, Pauline; Hielscher, Carsten; Meyer, Julia; Mundhenke, Christoph; Kurbacher, Christian; Untch, Michael; Janni, Wolfgang; Taran, Florin-Andrei; Lux, Michael P.; Wallwiener, Diethelm; Brucker, Sara Y.; Schneeweiss, Andreas; Fehm, Tanja N.; Wuerstlein, Rachel; Fremd, Carlo
errShare
errSave